Director Han Yusheng buys 314,870 shares of BNR at $17.36; stock down 60.6% from 52-week high
Han Yusheng, a Director at Burning Rock Biotech, purchased 314,870 shares at $17.36 on 2026-03-31 for a total value of $5,466,143.20, increasing his holdings from 17,357,806 shares to 17,672,676 shares (+1.8%). The timing of this purchase is notable given that BNR's current price of $16.20 reflects a 60.6% decline from its 52-week high of $41.06, with the stock down 31.2% over the past 30 days alone. While the purchase price at $17.36 was above the current price, the transaction occurred against a backdrop of significant recent share-price deterioration. The acquisition rate and holding size suggest a material position with ongoing engagement, though the absence of prior trading history and fundamentals data limits ability to contextualize the transaction within broader capital allocation patterns.